Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Epidemiology of gonorrhoea: a global perspective.

Kirkcaldy RD, Weston E, Segurado AC, Hughes G.

Sex Health. 2019 Sep 11. doi: 10.1071/SH19061. [Epub ahead of print]

PMID:
31505159
2.

Self-Reported History of Chlamydia or Gonorrhea Testing Among Heterosexual Women at High Risk of HIV Infection, National HIV Behavioral Surveillance, 2013.

Johnson Jones ML, Kirkcaldy RD, An Q, Gorwitz R, Bernstein K, Paz-Bailey G; NHBS Study Group.

Sex Transm Dis. 2019 Sep;46(9):608-616. doi: 10.1097/OLQ.0000000000001027.

PMID:
31415335
3.

Self-Reported Extragenital Chlamydia and Gonorrhea Testing in the Past 12 Months Among Men Who Have Sex with Men in the United States-American Men's Internet Survey, 2017.

de Voux A, Bernstein KT, Kirkcaldy RD, Zlotorzynska M, Sanchez T.

Sex Transm Dis. 2019 Sep;46(9):563-570. doi: 10.1097/OLQ.0000000000001032.

PMID:
31415039
4.

Association between trends in county-level opioid prescribing and reported rates of gonorrhea cases in the United States.

Abara WE, Hong J, Dorji T, Bohm MK, Weston EJ, Bernstein KT, Kirkcaldy RD.

Ann Epidemiol. 2019 Aug;36:26-32. doi: 10.1016/j.annepidem.2019.06.007. Epub 2019 Jul 4.

PMID:
31405718
5.

Self-Reported Infertility and Associated Pelvic Inflammatory Disease Among Women of Reproductive Age-National Health and Nutrition Examination Survey, United States, 2013-2016.

Anyalechi GE, Hong J, Kreisel K, Torrone E, Boulet S, Gorwitz R, Kirkcaldy RD, Bernstein K.

Sex Transm Dis. 2019 Jul;46(7):446-451. doi: 10.1097/OLQ.0000000000000996.

PMID:
31194716
6.

Gentamicin as an alternative treatment for gonorrhoea.

Kirkcaldy RD, Workowski KA.

Lancet. 2019 Jun 22;393(10190):2474-2475. doi: 10.1016/S0140-6736(19)30244-2. Epub 2019 May 2. No abstract available. Erratum in: Lancet. 2019 Jun 20;:. Lancet. 2019 Jun 29;393(10191):2590.

7.

Extragenital Chlamydia and Gonorrhea Among Community Venue-Attending Men Who Have Sex with Men - Five Cities, United States, 2017.

Johnson Jones ML, Chapin-Bardales J, Bizune D, Papp JR, Phillips C, Kirkcaldy RD, Wejnert C, Bernstein KT; National HIV Behavioral Surveillance Sexually Transmitted Infection Study Group.

MMWR Morb Mortal Wkly Rep. 2019 Apr 12;68(14):321-325. doi: 10.15585/mmwr.mm6814a1.

8.

Disseminated gonococcal infections in patients receiving eculizumab: a case series.

Crew PE, Abara WE, McCulley L, Waldron PE, Kirkcaldy RD, Weston EJ, Bernstein KT, Jones SC, Bersoff-Matcha SJ.

Clin Infect Dis. 2018 Nov 12. doi: 10.1093/cid/ciy958. [Epub ahead of print]

PMID:
30418536
9.

Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.

Cristillo AD, Bristow CC, Torrone E, Dillon JA, Kirkcaldy RD, Dong H, Grad YH, Nicholas RA, Rice PA, Lawrence K, Oldach D, Shafer WM, Zhou P, Wi TE, Morris SR, Klausner JD.

Sex Transm Dis. 2019 Mar;46(3):e18-e25. doi: 10.1097/OLQ.0000000000000929.

10.

Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.

Olesen SW, Torrone EA, Papp JR, Kirkcaldy RD, Lipsitch M, Grad YH.

J Infect Dis. 2019 Jan 29;219(4):619-623. doi: 10.1093/infdis/jiy551.

PMID:
30239814
11.

Multistate Syphilis Outbreak Among American Indians, 2013 to 2015.

Bowen VB, Peterman TA, Calles DL, Thompson AR, Kirkcaldy RD, Taylor MM.

Sex Transm Dis. 2018 Oct;45(10):690-695. doi: 10.1097/OLQ.0000000000000809.

PMID:
30204746
12.

Screening Peter to Save Paul: The Population-Level Effects of Screening Men Who Have Sex With Men for Gonorrhea and Chlamydia.

Ridpath AD, Chesson H, Marcus JL, Kirkcaldy RD, Torrone EA, Aral SO, Bernstein KT.

Sex Transm Dis. 2018 Sep;45(9):623-625. doi: 10.1097/OLQ.0000000000000892. No abstract available.

13.

Syphilis Testing Among Sexually Active Men Who Have Sex With Men and Who Are Receiving Medical Care for Human Immunodeficiency Virus in the United States: Medical Monitoring Project, 2013-2014.

de Voux A, Bernstein KT, Bradley H, Kirkcaldy RD, Tie Y, Shouse RL; Medical Monitoring Project.

Clin Infect Dis. 2019 Mar 5;68(6):934-939. doi: 10.1093/cid/ciy571.

PMID:
29985985
14.

A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned.

Hook EW 3rd, Kirkcaldy RD.

Clin Infect Dis. 2018 Sep 28;67(8):1294-1299. doi: 10.1093/cid/ciy271. Review.

15.

An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea.

Chesson HW, Kirkcaldy RD, Gift TL, Owusu-Edusei K Jr, Weinstock HS.

Sex Transm Dis. 2018 Apr;45(4):250-253. doi: 10.1097/OLQ.0000000000000725.

16.

Narrative Review: Assessment of Neisseria gonorrhoeae Infections Among Men Who Have Sex With Men in National and Sentinel Surveillance Systems in the United States.

Weston EJ, Kirkcaldy RD, Stenger M, Llata E, Hoots B, Torrone EA.

Sex Transm Dis. 2018 Apr;45(4):243-249. doi: 10.1097/OLQ.0000000000000740. Review.

17.

Considering the Potential Application of Whole Genome Sequencing to Gonorrhea Prevention and Control.

Kirkcaldy RD, Town K, Gernert KM, Bowen VB, Torrone EA, Kersh EN, Bernstein KT.

Sex Transm Dis. 2018 Jun;45(6):e29-e32. doi: 10.1097/OLQ.0000000000000813. No abstract available.

18.

Susceptibility of Neisseria gonorrhoeae to Gentamicin-Gonococcal Isolate Surveillance Project, 2015-2016.

Mann LM, Kirkcaldy RD, Papp JR, Torrone EA.

Sex Transm Dis. 2018 Feb;45(2):96-98. doi: 10.1097/OLQ.0000000000000693.

19.

Re-emerging and newly recognized sexually transmitted infections: Can prior experiences shed light on future identification and control?

Bernstein K, Bowen VB, Kim CR, Counotte MJ, Kirkcaldy RD, Kara E, Bolan G, Low N, Broutet N.

PLoS Med. 2017 Dec 27;14(12):e1002474. doi: 10.1371/journal.pmed.1002474. eCollection 2017 Dec.

20.

Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.

Kirkcaldy RD, Bartoces MG, Soge OO, Riedel S, Kubin G, Del Rio C, Papp JR, Hook EW 3rd, Hicks LA.

Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.

21.

Kiss and Tell: Limited Empirical Data on Oropharyngeal Neisseria gonorrhoeae Among Men Who Have Sex With Men and Implications for Modeling.

Bernstein KT, Chesson H, Kirkcaldy RD, Marcus JL, Gift TL, Aral SO.

Sex Transm Dis. 2017 Oct;44(10):596-598. doi: 10.1097/OLQ.0000000000000709. No abstract available.

22.

Genomic Characterization of Urethritis-Associated Neisseria meningitidis Shows that a Wide Range of N. meningitidis Strains Can Cause Urethritis.

Ma KC, Unemo M, Jeverica S, Kirkcaldy RD, Takahashi H, Ohnishi M, Grad YH.

J Clin Microbiol. 2017 Dec;55(12):3374-3383. doi: 10.1128/JCM.01018-17. Epub 2017 Sep 13.

23.

A Case of Decreased Susceptibility to Ceftriaxone in Neisseria gonorrhoeae in the Absence of a Mosaic Penicillin-Binding Protein 2 (penA) Allele.

Abrams AJ, Kirkcaldy RD, Pettus K, Fox JL, Kubin G, Trees DL.

Sex Transm Dis. 2017 Aug;44(8):492-494. doi: 10.1097/OLQ.0000000000000645.

PMID:
28703729
24.

Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.

Katz AR, Komeya AY, Kirkcaldy RD, Whelen AC, Soge OO, Papp JR, Kersh EN, Wasserman GM, O'Connor NP, O'Brien PS, Sato DT, Maningas EV, Kunimoto GY, Tomas JE.

Clin Infect Dis. 2017 Sep 15;65(6):918-923. doi: 10.1093/cid/cix485.

25.

Large Cluster of Neisseria meningitidis Urethritis in Columbus, Ohio, 2015.

Bazan JA, Turner AN, Kirkcaldy RD, Retchless AC, Kretz CB, Briere E, Tzeng YL, Stephens DS, Maierhofer C, Del Rio C, Abrams AJ, Trees DL, Ervin M, Licon DB, Fields KS, Roberts MW, Dennison A, Wang X.

Clin Infect Dis. 2017 Jul 1;65(1):92-99. doi: 10.1093/cid/cix215.

26.

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.

Papp JR, Abrams AJ, Nash E, Katz AR, Kirkcaldy RD, O'Connor NP, O'Brien PS, Harauchi DH, Maningas EV, Soge OO, Kersh EN, Komeya A, Tomas JE, Wasserman GM, Kunimoto GY, Trees DL, Whelen AC.

Emerg Infect Dis. 2017 May;23(5):830-832. doi: 10.3201/eid2305.170088.

27.

Considerations for Strengthening Surveillance of Neisseria gonorrhoeae Antimicrobial Resistance and Interpreting Surveillance Data.

Kirkcaldy RD, Schlanger K, Papp JR, Torrone EA.

Sex Transm Dis. 2017 Mar;44(3):154-156. doi: 10.1097/OLQ.0000000000000584. No abstract available.

28.

Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.

Grad YH, Harris SR, Kirkcaldy RD, Green AG, Marks DS, Bentley SD, Trees D, Lipsitch M.

J Infect Dis. 2016 Nov 15;214(10):1579-1587. Epub 2016 Sep 16.

29.

Elevated Risk for Antimicrobial Drug-Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011-2015.

Bowen A, Grass J, Bicknese A, Campbell D, Hurd J, Kirkcaldy RD.

Emerg Infect Dis. 2016 Sep;22(9):1613-6. doi: 10.3201/eid2209.160624.

30.

In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione.

Papp JR, Lawrence K, Sharpe S, Mueller J, Kirkcaldy RD.

Int J Antimicrob Agents. 2016 Sep;48(3):328-30. doi: 10.1016/j.ijantimicag.2016.05.018. Epub 2016 Jul 12.

31.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, Hook EW 3rd, Kubin G, Riedel S, Zenilman J, Pettus K, Sanders T, Sharpe S, Torrone E.

MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.

PMID:
27414503
32.

Early Identification and Prevention of the Spread of Ebola - United States.

Van Beneden CA, Pietz H, Kirkcaldy RD, Koonin LM, Uyeki TM, Oster AM, Levy DA, Glover M, Arduino MJ, Merlin TL, Kuhar DT, Kosmos C, Bell BP.

MMWR Suppl. 2016 Jul 8;65(3):75-84. doi: 10.15585/mmwr.su6503a11.

PMID:
27386933
33.

Notes from the Field: Increase in Neisseria meningitidis-Associated Urethritis Among Men at Two Sentinel Clinics - Columbus, Ohio, and Oakland County, Michigan, 2015.

Bazan JA, Peterson AS, Kirkcaldy RD, Briere EC, Maierhofer C, Turner AN, Licon DB, Parker N, Dennison A, Ervin M, Johnson L, Weberman B, Hackert P, Wang X, Kretz CB, Abrams AJ, Trees DL, Del Rio C, Stephens DS, Tzeng YL, DiOrio M, Roberts MW.

MMWR Morb Mortal Wkly Rep. 2016 Jun 3;65(21):550-2. doi: 10.15585/mmwr.mm6521a5.

34.

Increased Gonorrhea Screening and Case Finding After Implementation of Expanded Screening Criteria-Urban Indian Health Service Facility in Phoenix, Arizona, 2011-2013.

Patton ME, Kirkcaldy RD, Chang DC, Markman S, Yellowman M, Petrosky E, Adams L, Robinson C, Gupta A, Taylor MM.

Sex Transm Dis. 2016 Jun;43(6):396-401. doi: 10.1097/OLQ.0000000000000457.

35.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Kirkcaldy RD, Hook EW 3rd, Soge OO, del Rio C, Kubin G, Zenilman JM, Papp JR.

JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347. No abstract available.

36.

Clinical Inquiries Received by CDC Regarding Suspected Ebola Virus Disease in Children--United States, July 9, 2014-January 4, 2015.

Goodman AB, Meites E, Anstey EH, Fullerton KE, Jayatilleke A, Ruben W, Koumans E, Oster AM, Karwowski MP, Dziuban E, Kirkcaldy RD, Glover M, Lowe L, Peacock G, Mahon B, Griese SE.

MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1006-10. doi: 10.15585/mmwr.mm6436a3.

37.

Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.

Kidd S, Moore PC, Kirkcaldy RD, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Venkatasubramanian L, Ghanem KG, Hook EW 3rd.

Sex Transm Dis. 2015 Aug;42(8):434-9. doi: 10.1097/OLQ.0000000000000312.

38.

Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Kirkcaldy RD, Soge O, Papp JR, Hook EW 3rd, del Rio C, Kubin G, Weinstock HS.

Antimicrob Agents Chemother. 2015 Feb;59(2):998-1003. doi: 10.1128/AAC.04337-14. Epub 2014 Dec 1.

39.

Can the Perinatal Information System in Peru be used to measure the proportion of adverse birth outcomes attributable to maternal syphilis infection?

Bradley H, Tapia V, Kamb ML, Newman LM, Garcia PJ, Serruya SJ, Fort AL, Broutet N, Nelson R, Kirkcaldy RD, Gonzales GF.

Rev Panam Salud Publica. 2014 Aug;36(2):73-9.

PMID:
25345527
40.

Congenital syphilis investigation processes and timing in Louisiana.

Bradley H, Gruber D, Introcaso CE, Foxhood J, Wendell D, Rahman M, Ewell J, Kirkcaldy RD, Weinstock HS.

Sex Transm Dis. 2014 Sep;41(9):560-3. doi: 10.1097/OLQ.0000000000000167.

41.

Antimicrobial Resistance in Neisseria gonorrhoeae.

Kidd S, Kirkcaldy RD, Burstein GR.

Adolesc Med State Art Rev. 2014 Aug;25(2):316-31. No abstract available.

42.

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Johnson S, Ghanem KG, Hook EW 3rd.

Clin Infect Dis. 2014 Oct 15;59(8):1083-91. doi: 10.1093/cid/ciu521. Epub 2014 Jul 16.

43.

Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006.

Chesson HW, Kirkcaldy RD, Gift TL, Owusu-Edusei K Jr, Weinstock HS.

Emerg Infect Dis. 2014 Apr;20(4):612-9. doi: 10.3201/eid2004.131288.

44.

Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012.

Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, Bernstein K, Gratzer B, Jespersen M, Kerani R, Mettenbrink C, Mohamed M, Pathela P, Schumacher C, Stirland A, Stover J, Tabidze I, Kirkcaldy RD, Weinstock H.

Clin Infect Dis. 2014 Jun;58(11):1564-70. doi: 10.1093/cid/ciu184. Epub 2014 Mar 18.

45.

Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013.

Heiman KE, Karlsson M, Grass J, Howie B, Kirkcaldy RD, Mahon B, Brooks JT, Bowen A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 14;63(6):132-3.

46.

Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.

Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Weinstock H, Parkhill J, Hanage WP, Bentley S, Lipsitch M.

Lancet Infect Dis. 2014 Mar;14(3):220-6. doi: 10.1016/S1473-3099(13)70693-5. Epub 2014 Jan 22.

47.

Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.

Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv5-10. doi: 10.1136/sextrans-2013-051162.

PMID:
24243881
48.

Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.

Kidd S, Lee MV, Maningas E, Komeya A, Kunimoto G, O'Connor N, Katz AR, Wasserman GM, Kirkcaldy RD, Whelen AC.

Sex Transm Dis. 2013 Sep;40(9):756-9. doi: 10.1097/01.olq.0000431357.18959.30.

49.

Cephalosporin resistance in Neisseria gonorrhoeae infections--reply.

Kirkcaldy RD, Bolan GA, Wasserheit JN.

JAMA. 2013 May 15;309(19):1990-1. doi: 10.1001/jama.2013.4084. No abstract available.

50.

Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.

Kirkcaldy RD, Zaidi A, Hook EW 3rd, Holmes KK, Soge O, del Rio C, Hall G, Papp J, Bolan G, Weinstock HS.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):321-8. doi: 10.7326/0003-4819-158-5-201303050-00004. Erratum in: Ann Intern Med. 2013 Sep 3;159(5):372. Holmes, King H [corrected to Holmes, King K].

Supplemental Content

Loading ...
Support Center